Clinical Trials

NCT06979453 | RECRUITING | PHASE3

366 participants

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-12-03

Completion:

2029-10-12

Conditions

• Plaque Psoriasis

Interventions

• DRUG
• OTHER

No Results Yet

NCT06976268 | RECRUITING | PHASE2/PHASE3

550 participants

A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-05-28

Completion:

2027-08-31

Conditions

• Parkinson Disease

Interventions

• DRUG

No Results Yet

NCT06975176 | NOT_YET_RECRUITING | NA

155 participants

Combating HIV Stigma in Healthcare Settings: A Standardized Patient Approach

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2026-11-01

Completion:

2028-10-31

Conditions

• Hiv

Interventions

• BEHAVIORAL

No Results Yet

NCT06966700 | RECRUITING | PHASE3

2400 participants

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-06-30

Completion:

2033-03-23

Conditions

• Breast Neoplasms
• Triple Negative Breast Neoplasms
• HR Low-Positive/HER2-Negative Breast Neoplasms

Interventions

• BIOLOGICAL
• DRUG

No Results Yet

NCT06966492 | NOT_YET_RECRUITING | PHASE4

20 participants

Investigation of the Interplay Between Local Oral Inflammation, Microbiota and Systemic Immune Responses.

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2026-09-30

Completion:

2027-06-30

Conditions

• Gingival Inflammation

Interventions

• DRUG

No Results Yet

NCT06962839 | RECRUITING | PHASE2

300 participants

A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-06-05

Completion:

2027-09-01

Conditions

• Macular Edema

Interventions

• DRUG

No Results Yet

NCT06960564 | RECRUITING | NA

50 participants

The Effect of Hyaluronic Acid Injection on TNF-Alpha and IL-1β in Knee Osteoarthritis

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-05-12

Completion:

2026-09-02

Conditions

• Knee Osteoarthritis
• Hyaluronic Acid

Interventions

• DEVICE
• OTHER

No Results Yet

NCT06959979 | RECRUITING | EARLY_PHASE1

60 participants

Novel Molecular Targets and Innovative Therapeutic Perspective in Medulloblastoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2024-11-25

Completion:

2026-08-31

Conditions

• Medulloblastoma, Childhood

Interventions

• DRUG

No Results Yet

NCT06947499 | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3

1186 participants

A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-05-30

Completion:

2028-02-28

Conditions

• Diphtheria
• Tetanus
• Pertussis
• Hepatitis B
• Poliomyelitis
• Haemophilus Influenzae Type b

Interventions

• BIOLOGICAL

No Results Yet

NCT06944067 | RECRUITING

50 participants

Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease

Study Type:

OBSERVATIONAL

Last Updated:

2026-09-03

Start Date:

2025-06-24

Completion:

2030-04-10

Conditions

• Sickle Cell Disease

No Results Yet

NCT06936709 | NOT_YET_RECRUITING | PHASE4

75 participants

Perioperative Colchicine for TKA

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2026-12-01

Completion:

2027-01-01

Conditions

• Osteoarthritis of Knee
• Recovery Following Primary Total Knee Arthroplasty
• Perioperative Pain Control

Interventions

• DRUG

No Results Yet

NCT06935370 | RECRUITING | PHASE3

4200 participants

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-05-20

Completion:

2029-02-04

Conditions

• Heart Failure

Interventions

• DRUG

No Results Yet

NCT06930495 | ENROLLING_BY_INVITATION

95 participants

The Effect of Adiposity on Muscle and Microvascular Function in HFpEF

Study Type:

OBSERVATIONAL

Last Updated:

2026-09-03

Start Date:

2024-12-10

Completion:

2028-03-01

Conditions

• Heart Failure With Preserved Ejection Fraction (HFPEF)

Interventions

• DRUG

No Results Yet

NCT06925737 | RECRUITING | PHASE3

1440 participants

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-05-13

Completion:

2028-06-26

Conditions

• Prostate Cancer
• Prostatic Neoplasms

Interventions

• DRUG

No Results Yet

NCT06922617 | RECRUITING | NA

240 participants

STEPS: Substance Use Trial of E-cigarettes or Pharmacotherapy for Smoking

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-10-17

Completion:

2028-09-01

Conditions

• Tobacco Use
• Substance Use Disorders

Interventions

• BEHAVIORAL
• DRUG

No Results Yet

NCT06922448 | COMPLETED | PHASE2

21 participants

Study of BLU-808 in Allergic Rhinoconjunctivitis

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-04-14

Completion:

2025-09-08

Conditions

• Allergic Rhinoconjunctivitis

Interventions

• DRUG

No Results Yet

NCT06922110 | ENROLLING_BY_INVITATION | PHASE3

460 participants

An Open-Label Study of Azetukalner in Major Depressive Disorder

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-03-18

Completion:

2027-01-31

Conditions

• Major Depressive Disorder

Interventions

• DRUG

No Results Yet

NCT06921785 | RECRUITING | PHASE3

1220 participants

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-05-06

Completion:

2030-03-15

Conditions

• Hepatocellular Carcinoma

Interventions

• DRUG

No Results Yet

NCT06919653 | NOT_YET_RECRUITING | NA

60 participants

Promoting Adherence to Chemotherapy Handling Guidelines Among Oncology Nurses

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2026-10-31

Completion:

2027-08-31

Conditions

• Chemotherapy Exposure
• Handling Guidelines
• Oncology Nurse
• Adherence

Interventions

• BEHAVIORAL

No Results Yet

NCT06917911 | RECRUITING | PHASE2

162 participants

Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2027-02-02

Completion:

2027-11-25

Conditions

• Core Binding Factor Acute Myeloid Leukemia

Interventions

• PROCEDURE
• DRUG

No Results Yet

NCT06916793 | RECRUITING | PHASE3

288 participants

A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic Alopecia

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-04-08

Completion:

2027-09-30

Conditions

• Androgenetic Alopecia

Interventions

• DRUG

No Results Yet

NCT06909825 | ACTIVE_NOT_RECRUITING | PHASE2

85 participants

FPI-2265 (225Ac-PSMA-I&T) and Olaparib for Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-02-26

Completion:

2027-05-31

Conditions

• Metastatic Castration-resistant Prostate Cancer

Interventions

• DRUG

No Results Yet

NCT06905834 | NOT_YET_RECRUITING | PHASE2

30 participants

Evaluation of Allogenic Mesenchymal Stem Cell (MSC) Injection Therapy for Refractory Graft-versus-Host Disease (GVHD) Unresponsive to Conventional Treatments

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2026-10-31

Completion:

2027-06-30

Conditions

• Dry Eye Disease (DED)
• Graft-Versus-Host Disease(GVHD)

Interventions

• DRUG

No Results Yet

NCT06902519 | ACTIVE_NOT_RECRUITING | PHASE1

65 participants

Study of GS-0151 in Participants With Rheumatoid Arthritis

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-05-14

Completion:

2027-03-31

Conditions

• Rheumatoid Arthritis

Interventions

• DRUG

No Results Yet

NCT06902402 | COMPLETED | NA

123 participants

Evaluation of Safety and Efficacy of Three Flavors of Supportan® Drink in Cancer Patients in Taiwan

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-04-08

Completion:

2025-12-12

Conditions

• Cancer
• Malnutrition (Calorie)

Interventions

• DIETARY_SUPPLEMENT

No Results Yet

NCT06902311 | RECRUITING | PHASE2

90 participants

Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-02-19

Completion:

2028-02-29

Conditions

• Breast Cancer
• Early-stage Breast Cancer
• Ductal Carcinoma in Situ
• DCIS

Interventions

• RADIATION

No Results Yet

NCT06899087 | RECRUITING

45 participants

DEciphering CIrculating SIgnatures Of Infected Pancreatic Necrosis

Study Type:

OBSERVATIONAL

Last Updated:

2026-09-03

Start Date:

2025-07-01

Completion:

2027-09-01

Conditions

• Acute Pancreatitis

Interventions

• OTHER

No Results Yet

NCT06896201 | ACTIVE_NOT_RECRUITING | NA

200 participants

Comfortage - AD Prevention Strategies

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-10-07

Completion:

2027-03-31

Conditions

• Alzheimer Disease
• Subjective Cognitive Impairment
• Mild Cognitive Impairment

Interventions

• DIAGNOSTIC_TEST
• BIOLOGICAL
• OTHER
• DEVICE

No Results Yet

NCT06891456 | RECRUITING | NA

40 participants

Pulsed Field Ablation for Post-Infarction Ventricular Tachycardia

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-06-16

Completion:

2028-12-31

Conditions

• Ventricular Tachycardia
• Ischemic Heart Disease
• Sustained VT

Interventions

• DEVICE

No Results Yet

NCT06890884 | RECRUITING | PHASE2

594 participants

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-04-11

Completion:

2027-12-13

Conditions

• Lymphoma, Large B-Cell, Diffuse

Interventions

• BIOLOGICAL
• DRUG

No Results Yet

NCT06884774 | COMPLETED | NA

200 participants

Hemorrhoidectomy With or Without Lateral Internal Sphincterotomy in Management of Patients With Hemorrhoids

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2024-12-20

Completion:

2025-09-01

Conditions

• Lateral Internal Sphincterotomy
• Hemorrhoidectomy
• Hemorrhoids

Interventions

• PROCEDURE

No Results Yet

NCT06883305 | RECRUITING | PHASE3

990 participants

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-03-18

Completion:

2029-03-13

Conditions

• Chronic Obstructive Pulmonary Disease (COPD)

Interventions

• BIOLOGICAL
• OTHER

No Results Yet

NCT06878261 | RECRUITING | PHASE3

990 participants

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-03-25

Completion:

2029-03-13

Conditions

• Chronic Obstructive Pulmonary Disease (COPD)

Interventions

• BIOLOGICAL
• OTHER

No Results Yet

NCT06877104 | COMPLETED | NA

156 participants

Healing at Home 2.0 - Enhanced Chat Tool for Lowering Postpartum Depression

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-03-13

Completion:

2026-08-18

Conditions

• Depression, Postpartum
• Postpartum Care

Interventions

• OTHER

No Results Yet

NCT06872892 | RECRUITING | PHASE3

1755 participants

The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-06-09

Completion:

2027-06-15

Conditions

• Bronchiectasis

Interventions

• DRUG

No Results Yet

NCT06854393 | RECRUITING | PHASE2

88 participants

Lacripep for Corneal Wound Healing Study

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-05-23

Completion:

2027-06-30

Conditions

• Corneal Epithelial Wound Healing

Interventions

• DRUG

No Results Yet

NCT06851767 | ENROLLING_BY_INVITATION | PHASE1/PHASE2

18 participants

Base-Edited Hematopoietic Stem/Progenitor Cell X-Linked Severe Combined Immunodeficiency Gene Therapy

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-05-09

Completion:

2034-12-31

Conditions

• X-linked Severe Combined Immunodeficiency
• X-SCID
• XSCID

Interventions

• GENETIC
• DRUG
• BIOLOGICAL

No Results Yet

NCT06847880 | COMPLETED | PHASE1

56 participants

The Potential Effect of the Local Administration of Vitamins C and E on Orthodontic Treatment: A Randomized Clinical Trial

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-02-27

Completion:

2026-02-28

Conditions

• Pain Perception
• Root Resorption
• Rate of Orthodontic Tooth Movement
• Biomarkers

Interventions

• DRUG
• OTHER

No Results Yet

NCT06841354 | RECRUITING | PHASE3

1000 participants

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-03-16

Completion:

2030-05-18

Conditions

• Triple Negative Breast Neoplasms

Interventions

• BIOLOGICAL
• DRUG

No Results Yet

NCT06837896 | COMPLETED | PHASE3

111 participants

Efficacy and Safety Study of QLG1080 in Patients With Hormone-sensitive Advanced Prostate Cancer

Study Type:

INTERVENTIONAL

Last Updated:

2026-09-03

Start Date:

2025-03-11

Completion:

2026-01-15

Conditions

• Prostate Cancer

Interventions

• DRUG

No Results Yet